Selenium as an Element in the Treatment of Ovarian Cancer in Women Receiving Chemotherapy

March 2004 in “ Gynecologic oncology ”

Krzysztof Sieja, Małgorzata Talerczyk

New to Selenium? There is a guide in the encyclopedia. Read the guide →

selenium glutathione peroxidase malondialdehyde white blood cell hair loss Se GSH-Px MDA WBC

Studysummary This study concluded that selenium supplementation for ovarian cancer patients during chemotherapy may have several beneficial effects, such as increased antioxidant enzyme activity, reduced chemotherapy-related symptoms, and higher selenium levels in serum and hair.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer ·

View this study on gynecologiconcology-online.net →

Discuss this study in the Community →

Similar Research

5 / 1000+ results

research Selenium or No Selenium- That Is the Question in Tumor Patients: A New Controversy

61 citations , May 2010 in “Integrative Cancer Therapies”

This review discusses the potential benefits and risks of selenium in cancer prevention and treatment, emphasizing that while selenium may offer advantages for tumor patients, further research is needed due to mixed findings regarding diabetes risk.

research The Administration of Ocoxin Increases the Quality of Life of Patients with Advanced Epithelial or Metastatic Ovarian Cancer Undergoing Neoadjuvant Chemotherapy

1 citations , January 2022 in “Journal of Cancer Therapy”

In this study, Ocoxin used alongside chemotherapy may improve patients' tolerance to treatment and their quality of life without significant safety concerns, although further research is needed.

research SELENIUM

February 2010

This article provides an overview of various selenium-based products, their uses in treating conditions from cancer to dandruff, and lists potential adverse effects and interactions, but reports no new results.

research New Selenoderivatives as Antitumoral Agents

November 2011 in “InTech eBooks”

This review explores prostate cancer risk factors, screening, treatment, and potential roles of selenium and 5-alpha reductase inhibitors in risk reduction but presents no new clinical data.

Selenium and Systemic Lupus Erythematosus (SLE): A Double-Blind Randomized Controlled Trial

research selenium and systemic lupus erythematosus (SLE): A double- blind randomised controlled trial

April 2024 in “Research Square (Research Square)”

In this randomized trial, lupus patients taking daily 200 μg selenium supplements for eight weeks showed significant improvements in metabolic markers like CRP, ESR, MDA, and GPX, as well as reduced clinical symptoms such as arthritis and alopecia, compared to those receiving a placebo.